Safety Profile of Topical VEGF Neutralization at the Cornea
Investigative Ophthalmology & Visual Science2009Vol. 50(5), pp. 2095–2095
Citations Over TimeTop 10% of 2009 papers
Felix Bock, Jasmine Onderka, C. Rummelt, Tina Dietrich-Ntoukas, Björn Bachmann, Friedrich E. Kruse, Ursula Schlo ̈tzer-Schrehardt, Claus Cursiefen
Abstract
Topical neutralization of VEGF-A at the corneal surface does not have significant side effects on normal corneal epithelial wound healing, normal corneal integrity, or normal nerve fiber density. Therefore, anti-VEGF eyedrops seem to be a relatively safe option to treat corneal neovascularization.
Related Papers
- A model of angiogenesis in the mouse cornea.(1996)
- → Subconjunctival Bevacizumab Injection for Corneal Neovascularization(2008)145 cited
- → Vascular Endothelial Growth Factor in a Recipient Cornea Acts as a Prognostic Factor for Corneal Graft Reaction Development(2014)3 cited
- Relationship between the corneal neovascularization and vascular endothelial growth factor expression in corneal alkaline burn model(2005)
- Curative effect of subconjunctival injection of bevacizumab on angiogenesis in alkali burn cornea of rats(2009)